Article Information
History
- August 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- F. Javier Ibarrondo*,1,
- Christian Hofmann*,1,
- Ayub Ali*,1,
- Paul Ayoub2,
- Donald B. Kohn2,3 and
- Otto O. Yang, M.D1,2,†
- 1Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095
- 2Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095
- 3Division of Pediatric Hematology Oncology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095
- ↵†Corresponding author: Otto Yang, BSRB 173, 615 Charles E Young Drive South, Los Angeles, CA 90095, Phone: 310-794-9491, Facsimile: 310-983-1067, Email: oyang{at}mednet.ucla
↵* These authors contributed equally to this work
Posted August 29, 2021.
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies With Potency Against SARS-CoV-2 Variants
